✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹927 Cr.
P/E
96.78
  • Shukra Pharma
  • Wanbury
  • Kopran
FAQs on Shukra Pharmaceuticals Ltd. Shareprice

Shukra Pharma has given better returns compared to its competitors.
Shukra Pharma has grown at ~66.35% over the last 7yrs while peers have grown at a median rate of 30.05%

Yes, Shukra Pharma is expensive.
Latest PE of Shukra Pharma is 94.9, while 3 year average PE is 70.0.
Also latest EV/EBITDA of Shukra Pharma is 70.78 while 3yr average is 24.35.

Growth Table
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.
Balance Sheet
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
TTM Values as of Mar 2025
Cash Flow
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
Quarterly Results
  • Shukra Pharmaceuticals Ltd.
  • Wanbury
  • Kopran
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
80.00%
Implied Growth Rate over a 5 year period*
30.00%
Implied Growth Rate over a 10 year period*
14.00%
Implied Growth Rate over a 20 year period*
FAQs on Shukra Pharmaceuticals Ltd. Financials

Balance sheet of Shukra Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Shukra Pharma is increasing.
Latest net debt of Shukra Pharma is -₹7.94 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹16.64 Crs.

The profit is oscillating.
The profit of Shukra Pharma is ₹9.58 Crs for TTM, ₹18.54 Crs for Mar 2024 and ₹4.41 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Shukra Pharma latest dividend payout ratio is 5.9% and 3yr average dividend payout ratio is 6.92%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech